GLP-1 drugs (like Ozempic, Wegovy, and Mounjaro) are legitimate prescription medications for diabetes and weight loss, but they should only be prescribed by a health professional after an in-person consultation
Behavioural interventions remain foundational , and pharmacotherapy should complement rather than replace lifestyle modifications
Patient characteristics at baseline, treatment initiation, and after 1 year of follow-up are presented in Table 1
Key advantages include: First-to-market neuromodulative solution for neurogenic ED Scalable, cost-effective, and surgeon-independent : no fluoroscopy, no fixation screws, no specialized personnel required Patent-protected method and device , globally relevant across sexual medicine, urology, and gynecology Broad therapeutic potential in bladder, bowel, and pelvic pain disorders, significantly expanding the addressable market CONCLUSION NeuroGyn is not merely offering a treatment, it is redefining whats possible in male sexual health
By harnessing the power of both GIP and GLP-1 pathways, Tirzepatide offers a comprehensive approach to weight loss and glycemic control
